BioNTech SE (BNTX) Major Shareholders

Executive TeamFinancialsShareholders

BioNTech shareholders at a glance

The largest holder of BioNTech stock is Fidelity Management & Research Co. LLC, with 7.6 million shares (3.15% of the company), worth about $769.00 million as of September 25, 2026. The 10 largest holders together own 10.5%.

In Q2 2026, 320 institutional holdings reports listed 47.4 million shares worth $4.82 billion, down 0.2% in shares from Q1 2026.

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).

BNTX logo

BioNTech SE

BNTXGermany
Healthcare

Shareholders Summary

2026Q2

Filings
320
Options Value
$240.00M
Value (excl. Options)
$4.82B
Shares (excl. Options)
47.40M

Ownership by Type

Geographic Distribution

Largest BioNTech shareholders

HolderShares% of companyValue
Fidelity Management & Research Co. LLC7.6 million3.15%$769.0M
PRIMECAP Management Co.3.8 million1.57%$383.0M
Dodge & Cox3.7 million1.53%$374.0M
Flossbach von Storch SE2.2 million0.93%$226.0M
T. Rowe Price Investment Management, Inc.2.1 million0.86%$210.0M
Temasek Holdings Pte Ltd.1.5 million0.63%$153.0M
BNP Paribas Arbitrage SA1.3 million0.55%$134.0M
BlackRock Advisors LLC1.1 million0.46%$113.0M
Logos Global Management LP1.0 million0.42%$103.0M
Gsk PLC889,8240.37%$90.0M

As of September 25, 2026.

BioNTech institutional holdings by quarter

QuarterReportsSharesValue
Q2 202632047.4 million$4.8B
Q1 202630747.5 million$4.2B
Q4 202533051.1 million$4.9B
Q3 202529350.5 million$5.0B
Q2 202529553.8 million$5.7B
Q1 202531651.8 million$4.7B
Q4 202434750.9 million$5.8B
Q3 202435044.3 million$5.3B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Questions and answers

Who owns the most BioNTech stock?

Fidelity Management & Research Co. LLC, with 3.15% of the company (as of September 25, 2026). Next: PRIMECAP Management Co. (1.57%) and Dodge & Cox (1.53%).

How many institutions own BioNTech stock?

320 institutional holdings reports listed BioNTech shares in Q2 2026, 47.4 million shares in all worth $4.82 billion.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube